TNDM 241115 36.00P (TNDM241115P36000) Stock Options, News & Quotes

US OptionsDetailed Quotes

TNDM241115P36000

Watchlist

4.12
0.000.00%

15min DelayTrading Oct 17 10:22 ET

0.00High0.00Low

Intraday

5D
Daily

News

Down -21.69% in 4 Weeks, Here's Why Tandem Diabetes Care (TNDM) Looks Ripe for a Turnaround
Zacks Oct 18 08:45 ET
France Diabetes Devices Market Report (2024-2032) With Analysis by Type, Distribution Channel and Company - BD, Medtronic, Tandem Diabetes Care, Novo Nordisk, Roche, Abbott Labs, Eli Lilly, Ypsomed, Dexcom
Yahoo FinanceOct 15 09:13 ET
Stifel Maintains Tandem Diabetes Care(TNDM.US) With Buy Rating, Maintains Target Price $60
Moomoo NewsOct 14 11:31 ET · Ratings
Tandem Diabetes Care: Hold Rating Reiterated Amidst Market Challenges and Slow Product Uptake
TipRanksOct 13 11:05 ET · Ratings
RBC Capital Maintains Tandem Diabetes Care(TNDM.US) With Buy Rating, Maintains Target Price $65
Moomoo NewsOct 9 22:32 ET · Ratings
Tandem Diabetes Care Inc (TNDM) Q2 2024 Earnings Call Highlights: Strong Sales Growth and ...
InvestingOct 9 09:50 ET

Comments

mad541

Aug 2 11:48

company needs money this always drops 35% after earnings I'm out

mad541

Aug 2 11:46

$Tandem Diabetes Care (TNDM.US)$ company needs money this always drops 35% after earnings I'm out 🩸🩸🩸

Trytosaveabit

Aug 1 15:13

Update

$Tandem Diabetes Care (TNDM.US)$ Second Quarter 2024 Highlights
-- Worldwide GAAP sales increased 13 percent to $221.9 million compared to
second quarter 2023; worldwide non-GAAP sales(1) increased 12 percent to
$221.8 million compared to second quarter 2023.
-- More than 20,000 pumps shipped in the United States, a sequential
increase of 33 percent compared to first quarter 2024.
-- Launched Tandem Mobi with Dexcom G7 continuous glucose monitoring (CGM)
sensor integration in th...

70862468

May 21 11:11

Stock moves

$Tandem Diabetes Care (TNDM.US)$
Just check call options. they are expensive
However, stock price moves only 5-10% with no news. Something is going on behind the scene?!

Moomoo AI

Mar 22 05:56

Despite losses and negative cash flow, the company's US$178.2m balance sheet allows for at least two years of growth spending. However, the stock is seen as risky due to these financial conditions.

Is Tandem Diabetes Care (NASDAQ:TNDM) Using Debt In A Risky Way?